Resultados de la búsqueda 171-180 of 14008 for bloodwork without insurance

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG non-avid, ALK wild type (or ALK unknown) disease will be non-randomly assigned to receive current COG recommended high-risk therapy without ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Linvoseltamab has previously been studied as a single agent (without other cancer treatments) in participants with multiple myeloma that returned after prior ...

  6. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset. All ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to collect blood and tissue samples from patients with and without cancer to evaluate laboratory tests for early cancer ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset. All ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the effects of ibrutinib and rituximab with or without venetoclax in treating patients with previously untreated ...